Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Santiago Rodríguez-Segade"'
Autor:
María González-Rodríguez, Marcos Pazos-Couselo, José M. García-López, Santiago Rodríguez-Segade, Javier Rodríguez-García, Carmen Túñez-Bastida, Francisco Gude
Publikováno v:
Nutrition & Metabolism, Vol 16, Iss 1, Pp 1-9 (2019)
Abstract Background There is a growing interest in the pathopysiological consequences of postprandial hyperglycemia. It is well known that in diabetic patients 2 h plasma glucose is a better risk predictor for coronary heart disease than fasting plas
Externí odkaz:
https://doaj.org/article/953f6e4979b445ec8d3e85f3a937f824
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pediatric Allergy and Immunology. 32:465-478
Background Evidence about the association of high blood eosinophil count with asthma exacerbation is inconsistent and unclear. The objective of this meta-analysis was to determine whether elevated blood eosinophil count predicts asthma exacerbation.
Autor:
Marcos Pazos-Couselo, Arturo Gonzalez-Quintela, Luís Sanmartín-Portas, Félix Camiña, Francisco Gude, Javier Maseda Rodríguez, Santiago Rodríguez-Segade, Manuela Alonso-Sampedro, José Manuel García-López, Josefa Gerpe-Jamardo
Publikováno v:
Acta Diabetologica. 56:1023-1030
To investigate, in a sample of nondiabetic adults from a Spanish community, the differences between prediabetes as defined by HbA1c (“H-prediabetes”) and by fasting plasma glucose (FPG) (“F-prediabetes”) in regard to prevalence and the influe
Autor:
Santiago Rs-Alonso, Felipe F. Casanueva, Félix Camiña, Francisco Gude, José Manuel García-López, Santiago Rodríguez-Segade, Javier Rodriguez Garcia
Publikováno v:
Clinical Chemistry. 62:1570-1578
BACKGROUND Several hematological alterations are associated with altered hemoglobin A1c (Hb A1c). However, there have been no reports of their influence on the rates of exceeding standard Hb A1c thresholds by patients for whom Hb A1c determination is
Autor:
Santiago Rodríguez-Segade, Manuel Portolés, Oreste Gualillo, Alana Aragón-Herrera, Estefanía Tarazón, Javier Maseda Rodríguez, F. Lago, José Ramón González-Juanatey, Manuel Otero Santiago, Esther Roselló-Lletí, Sandra Feijóo-Bandín, Manuel Campos-Toimil, José Gil-Longo, Thiago de Melo Costa Pereira, Luis Barral, Tomás García-Caballero
Publikováno v:
Biochemical Pharmacology. 170:113677
The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial made evident the potentiality of pharmacological sodium-glucose cotransporter 2 (SGLT2) inhibition for treating patients w
Autor:
Manuela Alonso-Sampedro, Manuel Fernández-Arean, Santiago Rodríguez-Segade, Arturo Gonzalez-Quintela, Francisco Gude, José Manuel García-López, Félix Camiña, Marcos Pazos-Couselo, Javier Maseda Rodríguez, Vanessa García-Ciudad
Publikováno v:
Diabetes research and clinical practice. 142
Aims To investigate whether continuous glucose monitoring (CGM) reveals patterns of glycaemic behaviour, the detection of which might improve early diagnosis of dysglycaemia. Methods A total 1521 complete days of valid CGM data were recorded under re
Autor:
José Manuel García-López, Felipe F. Casanueva, Javier Maseda Rodríguez, Carmen Alonso de la Peña, Félix Camiña, Santiago Rodríguez-Segade, Ian C. Coleman
Publikováno v:
Acta Diabetologica. 52:453-459
The results of using HbA1C-based criteria for diagnosis of type 2 diabetes and prediabetes have been reported to differ from those obtained using fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT). We aimed to determine whether the
Autor:
Felipe F. Casanueva, July Rodriguez, Santiago Rodríguez-Segade, Félix Camiña, J. M. García López
Publikováno v:
Diabetic Medicine. 29:1562-1566
Diabet. Med. 29, 1562–1566 (2012) Abstract Aim To investigate the association between nephropathy and HbA1c variability (assessed as the standard deviation of each patient’s HbA1c measurements) among patients with Type 2 diabetes. Methods Albumin